KSPI Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
19:36
Aug 24
Author praises Kaspi as an outstanding company with elite management and notes the stock is up.
Author praises Kaspi as an outstanding company with elite management and notes the stock is up over 50% since mid-March, implying a bullish view.
KSPI
04:13
Jul 06
u/Away_Definition5829 Reddit r/ValueInvesting
Kaspi.kz trades at 6.8x P/E with an 8% dividend, Tencent as a strategic investor, and 23% founder ownership. The super-app model is undervalued relative to peers, and the Turkey expansion provides a new growth leg. A compelling value play with high insider alignment and a strong dividend yield, supported by a major tech partner. Kazakhstan political/regulatory risk; Turkey expansion may underperform; fintech competition.
KSPI 1ST
HIGH
06:22
Apr 20
Tencent investment and strong management drive value
Author is positive on Kaspi due to its strong management team, attractive valuation, high dividend, and recent investments by Tencent and management.
KSPI
MED
15:56
Mar 17
Included in fintech comparative research summary
Mentions the ticker in a comparative research summary of lending and fintech companies.
KSPI
LOW
15:12
Mar 12
Compressed valuation limits downside amid Turkey expansion
Summarizes Mohnish Pabrai's view that compressed valuation limits downside while Turkey expansion offers long-term growth potential.
KSPI
MED
14:41
Mar 09
Surprisingly low post-earnings despite high dividend yield
Observes the stock is surprisingly low post-earnings given its 10% dividend yield and high oil prices.
KSPI
MED
00:35
Mar 03
Myles Author, Value Zoomer (Substack)
Buy KSPI as the resolution of capital-return concerns de-risks the investment thesis.
KSPI
MED
14:30
Mar 02
KSPI aims for 100m users, Turkey expansion
Notes analyst call highlighting KSPI's expansion into Turkey and goal to become a 100m-user, multi-country company.
KSPI
LOW
12:59
Mar 02
KSPI reports cautious profit guidance, strong revenue
Earnings recap noting cautious profit guidance due to FX and taxes, but strong revenue and high dividend yield.
KSPI
MED
17:21
Feb 27
Expected strong EPS makes stock extremely cheap
Believes the stock is cheaper than ever ahead of an expected quarterly EPS announcement of over $3.0.
KSPI
MED
06:49
Feb 21
Author initiates new long position
Author discloses initiating a new long position, emphasizing the importance of building conviction through an absorbed investment framework.
KSPI
MED
16:57
Feb 20
Mohnish Pabrai purchases shares of KSPI
Notes that prominent investor Mohnish Pabrai has purchased the stock, aligning with his investment criteria.
KSPI
MED
15:37
Jan 17
Top holding based on management quality scores.
Author discloses their number one portfolio holding, citing high management scores based on Thorndike's "The Outsiders" criteria.
KSPI
MED
07:13
Jan 07
Stellar business and management drive Turkey expansion
Author praises the company's stellar business and world-class management, expressing confidence that its expansion into Turkey will succeed.
KSPI
MED
13:53
Dec 23
Discloses largest portfolio position for new year
Author discloses this as one of their largest portfolio positions going into the new year.
KSPI
MED
14:14
Nov 25
Strong EPS growth makes valuation highly attractive
Author is highly bullish on KSPI, noting that despite EPS more than doubling since 2021, the stock trades at a cheaper valuation than during the 2022 geopolitical panic.
KSPI
MED
12:27
Nov 10
Strong Q3 results overcome temporary issues
Expresses satisfaction with Q3 results, citing strong core growth and expecting temporary external issues to fade by early 2026.
KSPI
MED
12:19
Nov 10
Notes Q3 negatives and lowered guidance
Notes Q3 negatives including a loss-making Turkey business, smartphone sales bottlenecks, and slightly lowered FY25 guidance.
KSPI
MED
12:19
Nov 10
Highlights strong Q3 core business growth
Highlights strong Q3 core business growth of over 20% and highly profitable payments and fintech segments.
KSPI
MED
17:37
Oct 27
Elite management justifies adding to position
The long position in KSPI was increased despite an unfavorable macro environment, driven by confidence in the company's elite management team to navigate bad markets.
KSPI
MED
14:23
Oct 24
Existing long position increased in portfolio
An existing long position in KSPI was increased during a monthly portfolio update following a slight setback from record highs.
KSPI
MED
07:05
Oct 24
Temporary operational weakness presents buying opportunity
Current operational weakness in KSPI is temporary and expected to resolve by early 2026, presenting a good buying opportunity. The stock's correlation with oil prices is not based on real operational factors.
KSPI
MED
19:10
Oct 02
aleabitoreddit Reddit DD Author / Independent Trader
$KSPI looks like a good buy now.
KSPI
MED
06:16
Sep 25
Discloses reducing position in the stock
Author discloses reducing their position in the stock as part of a monthly portfolio update.
KSPI
MED
10:01
Aug 15
Author holds large KSPI position
Author discloses the stock is among their biggest current positions, highlighting positive earnings.
KSPI
MED
12:40
Aug 04
Capital returns expected after H2 problem resolution.
Expects current issues to be resolved in the second half of the year, leading to significant capital returns to shareholders starting next year.
KSPI
MED
08:38
Jul 31
aleabitoreddit Reddit DD Author / Independent Trader
$KSPI extremely good buy at $82 after 7.2% drop — bought $100k+, scaling to $250k cost average.
$KSPI extremely good buy at $82 after 7.2% drop — bought $100k+, scaling to $250k cost average. Fintech growing 47% Y/Y, 31% profit margins, 7.9 P/E.
KSPI 1ST
HIGH
14:21
Jul 14
Author lists largest current portfolio positions
Author discloses these names as their largest current portfolio positions, indicating ongoing bullish conviction and significant capital allocation.
KSPI
MED
15:38
Jun 10
Dismisses oil price impact on Q1 earnings
Notes Q1 earnings and dismisses concerns over oil price fluctuations as short-lived noise, advising focus on long-term information.
KSPI
MED
10:40
Jun 02
Author reduces existing position in portfolio update
Author discloses reducing their existing position in the stock as part of a broader portfolio update.
KSPI
MED

About KSPI Analyst Coverage

Buzzberg tracks KSPI across 4 sources. 4 bullish vs 0 bearish calls from 4 analysts. Sentiment: predominantly bullish (10%). 41 total trade ideas tracked. Latest voices: moodywriter13, u/Away_Definition5829, Myles.